Merck
  • Home
  • Search Results
  • Activity of second-generation ALK inhibitors against crizotinib-resistant mutants in an NPM-ALK model compared to EML4-ALK.

Activity of second-generation ALK inhibitors against crizotinib-resistant mutants in an NPM-ALK model compared to EML4-ALK.

Cancer medicine (2015-03-03)
Diletta Fontana, Monica Ceccon, Carlo Gambacorti-Passerini, Luca Mologni
ABSTRACT

Anaplastic lymphoma kinase (ALK) is a tyrosine kinase receptor involved in both solid and hematological tumors. About 80% of ALK-positive anaplastic large-cell lymphoma (ALCL) cases are characterized by the t(2;5)(p23;q35) translocation, encoding for the aberrant fusion protein nucleophosmin (NPM)-ALK, whereas 5% of non-small-cell lung cancer (NSCLC) patients carry the inv(2)(p21;p23) rearrangement, encoding for the echinoderm microtubule-associated protein-like 4 (EML4)-ALK fusion. The ALK/c-MET/ROS inhibitor crizotinib successfully improved the treatment of ALK-driven diseases. However, several cases of resistance appeared in NSCLC patients, and ALK amino acid substitutions were identified as a leading cause of resistance to crizotinib. Second-generation ALK inhibitors have been developed in order to overcome crizotinib resistance. In this work, we profiled in vitro the activity of crizotinib, AP26113, ASP3026, alectinib, and ceritinib against six mutated forms of ALK associated with clinical resistance to crizotinib (C1156Y, L1196M, L1152R, G1202R, G1269A, and S1206Y) and provide a classification of mutants according to their level of sensitivity/resistance to the drugs. Since the biological activity of ALK mutations extends beyond the specific type of fusion, both NPM-ALK- and EML4-ALK-positive cellular models were used. Our data revealed that most mutants may be targeted by using different inhibitors. One relevant exception is represented by the G1202R substitution, which was highly resistant to all drugs (>10-fold increased IC50 compared to wild type) and may represent the most challenging mutation to overcome. These results provide a prediction of cross-resistance of known crizotinib-resistant mutations against all second-generation tyrosine kinase inhibitors (TKIs) clinically available, and therefore could be a useful tool to help clinicians in the management of crizotinib-resistance cases.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
ジメチルスルホキシド, Hybri-Max, sterile-filtered, BioReagent, suitable for hybridoma, ≥99.7%
Sigma-Aldrich
ジメチルスルホキシド, for molecular biology
Sigma-Aldrich
ジメチルスルホキシド, anhydrous, ≥99.9%
Sigma-Aldrich
ジメチルスルホキシド, sterile-filtered, BioPerformance Certified, meets EP, USP testing specifications, suitable for hybridoma
Sigma-Aldrich
HEPES, ≥99.5% (titration)
Sigma-Aldrich
ドデシル硫酸ナトリウム, BioReagent, suitable for electrophoresis, for molecular biology, ≥98.5% (GC)
Sigma-Aldrich
HEPES, BioPerformance Certified, ≥99.5% (titration), suitable for cell culture
Sigma-Aldrich
トリパンブルー 溶液, 0.4%, liquid, sterile-filtered, suitable for cell culture
Sigma-Aldrich
ドデシル硫酸ナトリウム, ReagentPlus®, ≥98.5% (GC)
Sigma-Aldrich
ドデシル硫酸ナトリウム, ACS reagent, ≥99.0%
Sigma-Aldrich
ジメチルスルホキシド, ≥99.5% (GC), suitable for plant cell culture
Sigma-Aldrich
ドデシル硫酸ナトリウム 溶液, BioUltra, for molecular biology, 10% in H2O
Sigma-Aldrich
ドデシル硫酸ナトリウム, ≥99.0% (GC), dust-free pellets
Sigma-Aldrich
L-グルタミン, meets USP testing specifications, suitable for cell culture, 99.0-101.0%, from non-animal source
Sigma-Aldrich
HEPES緩衝液, 1 M in H2O
Sigma-Aldrich
アンピシリン, anhydrous, 96.0-102.0% (anhydrous basis)
Sigma-Aldrich
ジメチルスルホキシド, meets EP testing specifications, meets USP testing specifications
Sigma-Aldrich
ドデシル硫酸ナトリウム, BioXtra, ≥99.0% (GC)
Sigma-Aldrich
L-グルタミン, ReagentPlus®, ≥99% (HPLC)
Sigma-Aldrich
ドデシル硫酸ナトリウム, 92.5-100.5% based on total alkyl sulfate content basis
Sigma-Aldrich
ドデシル硫酸ナトリウム, BioUltra, for molecular biology, ≥99.0% (GC)
Sigma-Aldrich
ジメチルスルホキシド, BioUltra, for molecular biology, ≥99.5% (GC)
SAFC
HEPES
SAFC
L-グルタミン
Sigma-Aldrich
ドデシル硫酸ナトリウム 溶液, BioUltra, for molecular biology, 20% in H2O
Sigma-Aldrich
トリパンブルー, powder, BioReagent, suitable for cell culture
Sigma-Aldrich
HEPES, BioUltra, for molecular biology, ≥99.5% (T)
Sigma-Aldrich
HEPES, BioXtra, pH 5.0-6.5 (1 M in H2O), ≥99.5% (titration)
Sigma-Aldrich
ジメチルスルホキシド, PCR Reagent
SAFC
HEPES